On February 14, 2022, the Commission issued a notice of its final determination of a violation of section 337 and issuance of a general exclusion order ("GEO") in Certain Vaporizer Cartridges and...

On June 19, 2020, Novartis Pharma AG of Switzerland; Novartis Pharmaceuticals Corp. of East Hanover, New Jersey; and Novartis Technology LLC of East Hanover, New Jersey filed a complaint.

Today the Supreme Court denied cert in GSK v. Teva in which the Solicitor General filed a brief in support of granting cert. The Solicitor argued that the decision in GSK's favor...

The Congress passed and President on December 22 signed into law the "Further Extension of Continuing Appropriations Act, 2021"...

The U.S. Patent and Trademark Office has issued special accommodations for patent and trademark applicants affected by a severe earthquake in Japan on July 28, 2026. These measures include restarting response time periods...

On October 8th, the USPTO announced the Automated Search Pilot Program. This program will send an Automated Search Results Notice (ASRN) to the Applicant prior to examination so the Applicant can learn about potential prior art issues in the application.

A final ruling has been issued by the U.S. Patent and Trademark Office (USPTO) regarding applications which contain nucleotide and/or amino acid sequences. (OLD)

The Fee Schedule provides information and fee rates for products and services provided by the USPTO.

The USPTO recently proposed new fees, effective January 2021.

On May 10, 2024, the US Patent and Trademark Office (USPTO) introduced a proposed rule that could have significant implications for patent procedures, particularly concerning terminal disclaimers...

A 60-day public comment period, ending on September 30, 2019, is now open.

Further to our article of May 13, 2024 (here), the U.S. Patent and Trademark Office (USPTO) announced on December 4, 2024, that it is withdrawing the Notice of Proposed Rulemaking published in the Federal Register on May 10, 2024.

Oblon hosted a webinar on "Using the Amgen-Sanofi Methodology to Identify the Historic Treatment of Patent Eligibility Issues: Today's 35 U.S.C. § 101 Issues."

Almost 16 years ago, we wrote an article in Managing Intellectual Property (Nov. 2002, Issue 124) entitled U.S. DESIGN PATENTS: AN UNDERDOG THAT BITES.

Federal Courts and International Trade Commission - Coronavirus (COVID-19) Information.

The Supreme has relisted the petition for certiorari in Juno Therapeutics, Inc. v. Kite Pharma, Inc., 21-1566 where Juno petitioned for review of the Federal Circuit's decision...

On July 12, 2019, Dynamics Inc. of Cheswick, Pennsylvania ("Dynamics") filed a complaint requesting that the ITC commence an investigation pursuant to Section 337.

The case arose from an ITC investigation into sweeteners imported by a Chinese manufacturer, which allegedly infringed Celanese's patents.

On January 26, 2022, the ITC issued a Notice of Investigation in Certain Integrated Circuit Products and Devices Containing the Same (Inv. No. 337-TA-1295).

On June 7, 2022, the ITC issued a Notice of Investigation in Certain Electronic Devices and Semiconductor Devices With Timing-Aware Dummy Fill and Components Thereof (Inv. No. 337-TA-1319).